WAVECREST Post Market Clinical Follow-Up (PMCF) Study


Phase 3 Results N/A

Summary of Purpose

The WAVECREST PMCF Study is a prospective, non-randomized, multicenter study to confirm safety and performance of the Coherex WaveCrest Left Atrial Appendage (LAA) Occlusion System in the current medical practice setting in patients with non-valvular atrial fibrillation who are at increased risk for stroke. Up to 65 subjects may be enrolled at up to 15 study sites in Europe. Patients will be followed through 45...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 6 February 2018.

29 May 2017 16 Jun 2017 13 Jul 2018 13 Aug 2018 1 Feb 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available